← Eichor
Study identifier: NCT05821075 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Condition: Bell Palsy  ·  Sponsor: October 6 University

PhasePhase 1/Phase 2
Planned participants90
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

This description comes directly from the study's public registry record.

Talk to the study team

Engy Wahsh  ·  01003095692  ·  engywahsh@o6u.edu.eg

mohamed rez  ·  01006904056  ·  Abdelmaksodm.mousa@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

October 6 university hospitalGiza, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05821075